Balsalazide and mesalamine are aminosalicylate drugs (DMARDs) commonly used to treat ulcerative colitis by targeting peroxisome proliferator activated receptor gamma (PPARG) [61, 79]. The gene discussed is PPARG; the disease is ulcerative colitis.